Copyright Reports & Markets. All rights reserved.

Global Metabotropic Glutamate Receptor Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Metabotropic Glutamate Receptor Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Metabotropic Glutamate Receptor Market Size Growth Rate by Product
      • 1.4.2 Polysaccharide Vaccines
      • 1.4.3 Conjugate Vaccines
      • 1.4.4 Combination Vaccines
      • 1.4.5 Men B Vaccines
    • 1.5 Market by End User
      • 1.5.1 Global Metabotropic Glutamate Receptor Market Size Growth Rate by End User
      • 1.5.2 Meningitis
      • 1.5.3 Septicemia
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Metabotropic Glutamate Receptor Market Size
      • 2.1.1 Global Metabotropic Glutamate Receptor Revenue 2014-2025
      • 2.1.2 Global Metabotropic Glutamate Receptor Sales 2014-2025
    • 2.2 Metabotropic Glutamate Receptor Growth Rate by Regions
      • 2.2.1 Global Metabotropic Glutamate Receptor Sales by Regions
      • 2.2.2 Global Metabotropic Glutamate Receptor Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Metabotropic Glutamate Receptor Sales by Manufacturers
      • 3.1.1 Metabotropic Glutamate Receptor Sales by Manufacturers
      • 3.1.2 Metabotropic Glutamate Receptor Sales Market Share by Manufacturers
      • 3.1.3 Global Metabotropic Glutamate Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Metabotropic Glutamate Receptor Revenue by Manufacturers
      • 3.2.1 Metabotropic Glutamate Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Metabotropic Glutamate Receptor Revenue Share by Manufacturers (2014-2019)
    • 3.3 Metabotropic Glutamate Receptor Price by Manufacturers
    • 3.4 Metabotropic Glutamate Receptor Manufacturing Base Distribution, Product Types
      • 3.4.1 Metabotropic Glutamate Receptor Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Metabotropic Glutamate Receptor Product Type
      • 3.4.3 Date of International Manufacturers Enter into Metabotropic Glutamate Receptor Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Metabotropic Glutamate Receptor Sales by Product
    • 4.2 Global Metabotropic Glutamate Receptor Revenue by Product
    • 4.3 Metabotropic Glutamate Receptor Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Metabotropic Glutamate Receptor Breakdown Data by End User

    6 North America

    • 6.1 North America Metabotropic Glutamate Receptor by Countries
      • 6.1.1 North America Metabotropic Glutamate Receptor Sales by Countries
      • 6.1.2 North America Metabotropic Glutamate Receptor Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Metabotropic Glutamate Receptor by Product
    • 6.3 North America Metabotropic Glutamate Receptor by End User

    7 Europe

    • 7.1 Europe Metabotropic Glutamate Receptor by Countries
      • 7.1.1 Europe Metabotropic Glutamate Receptor Sales by Countries
      • 7.1.2 Europe Metabotropic Glutamate Receptor Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Metabotropic Glutamate Receptor by Product
    • 7.3 Europe Metabotropic Glutamate Receptor by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Metabotropic Glutamate Receptor by Countries
      • 8.1.1 Asia Pacific Metabotropic Glutamate Receptor Sales by Countries
      • 8.1.2 Asia Pacific Metabotropic Glutamate Receptor Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Metabotropic Glutamate Receptor by Product
    • 8.3 Asia Pacific Metabotropic Glutamate Receptor by End User

    9 Central & South America

    • 9.1 Central & South America Metabotropic Glutamate Receptor by Countries
      • 9.1.1 Central & South America Metabotropic Glutamate Receptor Sales by Countries
      • 9.1.2 Central & South America Metabotropic Glutamate Receptor Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Metabotropic Glutamate Receptor by Product
    • 9.3 Central & South America Metabotropic Glutamate Receptor by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Metabotropic Glutamate Receptor by Countries
      • 10.1.1 Middle East and Africa Metabotropic Glutamate Receptor Sales by Countries
      • 10.1.2 Middle East and Africa Metabotropic Glutamate Receptor Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Metabotropic Glutamate Receptor by Product
    • 10.3 Middle East and Africa Metabotropic Glutamate Receptor by End User

    11 Company Profiles

    • 11.1 Serum Institute (India)
      • 11.1.1 Serum Institute (India) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Serum Institute (India) Metabotropic Glutamate Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Serum Institute (India) Metabotropic Glutamate Receptor Products Offered
      • 11.1.5 Serum Institute (India) Recent Development
    • 11.2 Sanofi SA (France)
      • 11.2.1 Sanofi SA (France) Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi SA (France) Metabotropic Glutamate Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi SA (France) Metabotropic Glutamate Receptor Products Offered
      • 11.2.5 Sanofi SA (France) Recent Development
    • 11.3 Pfizer (USA)
      • 11.3.1 Pfizer (USA) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Pfizer (USA) Metabotropic Glutamate Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Pfizer (USA) Metabotropic Glutamate Receptor Products Offered
      • 11.3.5 Pfizer (USA) Recent Development
    • 11.4 Nuron Biotech (USA)
      • 11.4.1 Nuron Biotech (USA) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Nuron Biotech (USA) Metabotropic Glutamate Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Nuron Biotech (USA) Metabotropic Glutamate Receptor Products Offered
      • 11.4.5 Nuron Biotech (USA) Recent Development
    • 11.5 JN-International Medical (USA)
      • 11.5.1 JN-International Medical (USA) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 JN-International Medical (USA) Metabotropic Glutamate Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 JN-International Medical (USA) Metabotropic Glutamate Receptor Products Offered
      • 11.5.5 JN-International Medical (USA) Recent Development

    12 Future Forecast

    • 12.1 Metabotropic Glutamate Receptor Market Forecast by Regions
      • 12.1.1 Global Metabotropic Glutamate Receptor Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Metabotropic Glutamate Receptor Revenue Forecast by Regions 2019-2025
    • 12.2 Metabotropic Glutamate Receptor Market Forecast by Product
      • 12.2.1 Global Metabotropic Glutamate Receptor Sales Forecast by Product 2019-2025
      • 12.2.2 Global Metabotropic Glutamate Receptor Revenue Forecast by Product 2019-2025
    • 12.3 Metabotropic Glutamate Receptor Market Forecast by End User
    • 12.4 North America Metabotropic Glutamate Receptor Forecast
    • 12.5 Europe Metabotropic Glutamate Receptor Forecast
    • 12.6 Asia Pacific Metabotropic Glutamate Receptor Forecast
    • 12.7 Central & South America Metabotropic Glutamate Receptor Forecast
    • 12.8 Middle East and Africa Metabotropic Glutamate Receptor Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Metabotropic Glutamate Receptor Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
      The global Metabotropic Glutamate Receptor market is valued at 2 million US$ in 2018 and will reach 5 million US$ by the end of 2025, growing at a CAGR of 12.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Metabotropic Glutamate Receptor market based on company, product type, end user and key regions.

      This report studies the global market size of Metabotropic Glutamate Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Metabotropic Glutamate Receptor in these regions.
      This research report categorizes the global Metabotropic Glutamate Receptor market by top players/brands, region, type and end user. This report also studies the global Metabotropic Glutamate Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Serum Institute (India)
      Sanofi SA (France)
      Pfizer (USA)
      Nuron Biotech (USA)
      JN-International Medical (USA)

      Market size by Product
      Polysaccharide Vaccines
      Conjugate Vaccines
      Combination Vaccines
      Men B Vaccines
      Market size by End User
      Meningitis
      Septicemia
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Metabotropic Glutamate Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Metabotropic Glutamate Receptor market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Metabotropic Glutamate Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Metabotropic Glutamate Receptor submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Metabotropic Glutamate Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Metabotropic Glutamate Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now